These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21505038)

  • 1. Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptor.
    Thompson AJ; Duke RK; Lummis SC
    Mol Pharmacol; 2011 Jul; 80(1):183-90. PubMed ID: 21505038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginkgolide B and bilobalide block the pore of the 5-HT₃receptor at a location that overlaps the picrotoxin binding site.
    Thompson AJ; Jarvis GE; Duke RK; Johnston GA; Lummis SC
    Neuropharmacology; 2011; 60(2-3):488-95. PubMed ID: 21059362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bilobalide, ginkgolide B and picrotoxinin on GABA
    Ng CC; Duke RK; Hinton T; Johnston GAR
    Eur J Pharmacol; 2017 Jul; 806():83-90. PubMed ID: 28416372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAA receptor cysteinyl mutants and the ginkgo terpenoid lactones bilobalide and ginkgolides.
    Ng CC; Duke RK; Hinton T; Johnston GA
    Eur J Pharmacol; 2016 Apr; 777():136-46. PubMed ID: 26953225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylalanine in the pore of the Erwinia ligand-gated ion channel modulates picrotoxinin potency but not receptor function.
    Thompson AJ; Alqazzaz M; Price KL; Weston DA; Lummis SC
    Biochemistry; 2014 Oct; 53(39):6183-8. PubMed ID: 25238029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for the Val291 residue within the transmembrane domain 2 in diltiazem- and TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester]-mediated 5-hydroxytryptamine type 3A receptor regulations.
    Lee BH; Choi SH; Pyo MK; Shin TJ; Hwang SH; Kim BR; Lee JH; Rhim H; Kim HC; Nah SY
    Biol Pharm Bull; 2009 May; 32(5):861-7. PubMed ID: 19420755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant alpha1beta2gamma2L GABA(A) receptors.
    Huang SH; Duke RK; Chebib M; Sasaki K; Wada K; Johnston GA
    Eur J Pharmacol; 2003 Mar; 464(1):1-8. PubMed ID: 12600688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of biotic elicitors on the accumulation of bilobalide and ginkgolides in Ginkgo biloba cell cultures.
    Kang SM; Min JY; Kim YD; Karigar CS; Kim SW; Goo GH; Choi MS
    J Biotechnol; 2009 Jan; 139(1):84-8. PubMed ID: 18983879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
    Thompson AJ; Lummis SC
    Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative impact of residues at the intracellular and extracellular ends of the human GABAC rho1 receptor M2 domain on picrotoxinin activity.
    Carland JE; Johnston GA; Chebib M
    Eur J Pharmacol; 2008 Feb; 580(1-2):27-35. PubMed ID: 18031737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity analysis of ginkgolide binding in the glycine receptor pore.
    Heads JA; Hawthorne RL; Lynagh T; Lynch JW
    J Neurochem; 2008 May; 105(4):1418-27. PubMed ID: 18221374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncompetitive Inhibition of 5-HT3 Receptors by Citral, Linalool, and Eucalyptol Revealed by Nonlinear Mixed-Effects Modeling.
    Jarvis GE; Barbosa R; Thompson AJ
    J Pharmacol Exp Ther; 2016 Mar; 356(3):549-62. PubMed ID: 26669427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors.
    Thompson AJ; Verheij MH; Verbeek J; Windhorst AD; de Esch IJ; Lummis SC
    Neuropharmacology; 2014 Nov; 86():378-88. PubMed ID: 25174552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed antagonistic effects of bilobalide at rho1 GABAC receptor.
    Huang SH; Duke RK; Chebib M; Sasaki K; Wada K; Johnston GA
    Neuroscience; 2006; 137(2):607-17. PubMed ID: 16300902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
    Lochner M; Lummis SC
    Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ginsenoside interaction sites in 5-HT3A receptors.
    Lee BH; Lee JH; Lee SM; Jeong SM; Yoon IS; Lee JH; Choi SH; Pyo MK; Rhim H; Kim HC; Jang CG; Lee BC; Park CS; Nah SY
    Neuropharmacology; 2007 Mar; 52(4):1139-50. PubMed ID: 17257631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.
    Duffy NH; Lester HA; Dougherty DA
    ACS Chem Biol; 2012 Oct; 7(10):1738-45. PubMed ID: 22873819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
    Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
    Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.